Loading...
GRI Bio, Inc.
GRI•NASDAQ
Healthcare
Biotechnology
$1.32
$0.04(3.13%)
GRI Bio, Inc. (GRI) Financial Performance & Income Statement Overview
Review GRI Bio, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
27.68%
↑ 27.68%
Net Income Growth
37.05%
↑ 37.05%
Operating Cash Flow Growth
5.79%
↑ 5.79%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-275.15%
↓ 275.15%
ROIC
-743.55%
↓ 743.55%
GRI Bio, Inc. (GRI) Income Statement & Financial Overview
Review GRI Bio, Inc.'s (GRI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | ||
| R&D Expenses | $828000.00 | $1.13M | $877000.00 | $933000.00 |
| SG&A Expenses | $1.13M | $1.00M | $1.38M | $962000.00 |
| Operating Expenses | $1.95M | $2.13M | $2.26M | $1.90M |
| Total Costs & Expenses | $1.95M | $2.13M | $2.26M | $1.90M |
| Interest Income | $6000.00 | $7000.00 | $6000.00 | $6000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1000.00 | $1000.00 | $1000.00 | $1000.00 |
| EBITDA | -$1.95M | -$2.13M | -$2.26M | -$1.89M |
| EBITDA Ratio | ||||
| Operating Income | -$1.95M | -$2.13M | -$2.26M | -$1.90M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $6000.00 | $7000.00 | $7000.00 | $8000.00 |
| Income Before Tax | -$1.95M | -$2.12M | -$2.25M | -$1.89M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$1.95M | -$2.12M | -$2.25M | -$1.89M |
| Net Income Ratio | ||||
| EPS | $140.81 | -$11.42 | -$83.56 | -$101.04 |
| Diluted EPS | $140.81 | -$11.42 | -$83.56 | -$101.04 |
| Weighted Avg Shares Outstanding | $183276.00 | $185927.00 | $457725.00 | $317492.00 |
| Weighted Avg Shares Outstanding (Diluted) | $183276.00 | $185927.00 | $457725.00 | $317492.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan